BELLODI, LAURA
 Distribuzione geografica
Continente #
AS - Asia 4.747
EU - Europa 4.059
NA - Nord America 2.829
SA - Sud America 1.208
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 12.920
Nazione #
US - Stati Uniti d'America 2.709
RU - Federazione Russa 2.601
SG - Singapore 1.732
CN - Cina 1.614
BR - Brasile 995
SE - Svezia 696
HK - Hong Kong 602
VN - Vietnam 430
FR - Francia 253
DE - Germania 103
IT - Italia 101
AR - Argentina 89
GB - Regno Unito 80
IN - India 74
IE - Irlanda 72
CA - Canada 55
EC - Ecuador 40
FI - Finlandia 38
ID - Indonesia 38
BD - Bangladesh 37
MX - Messico 36
TR - Turchia 35
IQ - Iraq 34
JP - Giappone 31
CO - Colombia 28
ZA - Sudafrica 26
PK - Pakistan 23
PL - Polonia 23
AT - Austria 21
PY - Paraguay 16
UA - Ucraina 15
ES - Italia 14
UZ - Uzbekistan 14
VE - Venezuela 14
UY - Uruguay 12
CL - Cile 11
SA - Arabia Saudita 11
IR - Iran 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 7
NL - Olanda 7
PH - Filippine 7
DO - Repubblica Dominicana 6
EG - Egitto 6
NP - Nepal 6
BY - Bielorussia 5
GR - Grecia 5
LT - Lituania 5
XK - ???statistics.table.value.countryCode.XK??? 5
HN - Honduras 4
KE - Kenya 4
KR - Corea 4
LB - Libano 4
RS - Serbia 4
TN - Tunisia 4
AU - Australia 3
BB - Barbados 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
DK - Danimarca 3
JM - Giamaica 3
JO - Giordania 3
KG - Kirghizistan 3
KZ - Kazakistan 3
OM - Oman 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
KH - Cambogia 2
KW - Kuwait 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GY - Guiana 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MR - Mauritania 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
Totale 12.914
Città #
Singapore 675
Hong Kong 598
Moscow 584
Dallas 561
Ashburn 392
San Jose 374
Shanghai 306
Hefei 252
Lawrence 252
Princeton 249
Lauterbourg 211
Ho Chi Minh City 157
New York 99
Beijing 94
Hanoi 86
São Paulo 81
Dublin 72
Los Angeles 63
Santa Clara 38
Orem 33
The Dalles 32
Brasília 30
Helsinki 30
Milan 27
Rio de Janeiro 27
Belo Horizonte 26
Washington 26
Boardman 25
Brooklyn 23
Pune 23
Guangzhou 22
Haiphong 22
Guayaquil 20
Warsaw 20
Nuremberg 19
Columbus 18
London 18
Da Nang 17
Montreal 17
Tokyo 17
Chennai 16
Biên Hòa 15
Curitiba 15
Denver 14
Houston 14
Buenos Aires 13
Stockholm 13
Boston 12
Porto Alegre 12
Atlanta 11
Johannesburg 11
Manchester 11
Mexico City 11
Salvador 11
Shenzhen 11
Suita 11
Tashkent 11
Ankara 10
Baghdad 10
Changsha 10
Guarulhos 10
Hải Dương 10
Seattle 10
Sorocaba 10
Tianjin 10
Toronto 10
Frankfurt am Main 9
Gainesville 9
Karachi 9
Phoenix 9
San Francisco 9
Campinas 8
Chicago 8
Jakarta 8
Montevideo 8
Ninh Bình 8
Paris 8
Quito 8
Vienna 8
Asunción 7
Manaus 7
Medellín 7
Recife 7
Thái Bình 7
Bogotá 6
Canoas 6
Delhi 6
Dhaka 6
Hortolândia 6
Joinville 6
Kassel 6
Limeira 6
New Delhi 6
Poplar 6
Rome 6
São Bernardo do Campo 6
São Leopoldo 6
Turku 6
Uberlândia 6
Aracaju 5
Totale 6.177
Nome #
[F-18] FDG PET study in obsessive-compulsive disorder. A clinical metabolic correlation study after treatment 146
A psychometric-genetic study of schizotypal disorder 131
A FAMILY STUDY OF SCHIZOTYPAL DISORDER 125
5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder 116
Abnormal pattern of cortical activation associated with voluntary movement in obsessive-compulsive disorder: An EEG study 111
5% CO2 challenge in healthy first degree relatives of patients with panic disorder 108
AGE AT ONSET OF PANIC DISORDER - INFLUENCE OF FAMILIAL LIABILITY TO THE DISEASE AND OF CHILDHOOD SEPARATION ANXIETY DISORDER 105
35% CO2-65% O2 inhalation test in panic patients 104
A long-term prospective evaluation of first-degree relatives of panic patients who underwent the 35% CO2 challenge 104
A psychosocial risk factor model for female eating disorders: A European multicentre project 100
A neural network approach to the outcome definition on first treatment with sertraline in a psychiatric population 98
A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study 97
Age at onset of panic disorder: influence of familial liability to the disease and of childhood separation anxiety disorder. American Journal of Psychiatry, 152: 1362-1364, 1995 97
A new social-family model for eating disorders: A European multicentre project using a case–control design 95
A neuropsychological study of dissociation in cortical and subcortical functioning in Obsessive-Compulsive Disorder by Tower of Hanoi Task 95
Acoustic startle response in panic disorder 94
A combined population and family-based study of eight European populations demonstrates association between BDNF and eating disorders. 93
A segregation study for panic disorder families in which probands are responsive to 35% CO2 challenge test. 91
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 90
Assessment of parent-of-origin effect in families unlineally affected with panic disorder-agoraphobia 88
Visuo-tactile shape perception in women with Anorexia Nervosa and healthy women with and without body concerns 78
A segregation study of panic disorder in families of panic patients responsive to the 35% CO2 challenge 77
Emotional Intelligence in Panic Disorder 75
Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: A single-blind study 75
Assessment of parent-of-origin effect in families unilineally affected with Panic Disorder Agoraphobia. Journal of Psychiatric Research, 33: 37-39, 1999 74
Obsessive compulsive disorder and mood disorders: A family study 72
An assessment of the Wisconsin Card Sorting Test as an indicator of liability to schizophrenia. 69
Cross-disorder genome-wide analyses suggest a complex genetic relationship between tourette's syndrome and OCD 69
The Iowa Personality Disorder Screen: Development and preliminary validation of a brief screening interview 66
Perceived vs. desired body size estimations in samples of anorectic and bulimic patients - MANUSCRIPT IN PREPARATION 65
Dizziness, migrainous vertigo and psychiatric disorders 63
Clinical predictors of drug response in obsessive-compulsive disorder 63
Morbidity Risk For Mood Disorders In The Families Of Borderline Patients 63
Carbon Dioxide/Oxygen Challenge Test in Panic Disorder. 63
The structure of DSM-III-R schizotypal personality disorder diagnosed by direct interviews 63
Temperament dimensions explain comorbidity of psychiatric disorders. Comprehensive Psychiatry, 37 (4): 292-298, 1996 62
Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis 62
Familial risks and reproductive fitness in schizophrenia 61
Family history of panic disorder and hypersensitivity to CO2 in patients with panic disorder 61
Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study 61
An assessment of the Wisconsin Card Sorting Test as an indicator of liability to Schizophrenia. Schizophrenia Research, 14: 39-46, 1994 61
The Co-Occurrence of DSM III-R Personality Disorders. 60
Panic disorder: the role of the balance system 59
Psychiatric disorders in the families of schizotypal subjects. Schizophrenia Bulletin,17 (4): 659-668, 1991 59
Ambulatory polysomnography of never-depressed borderline subjects: a high-risk approach to rapid eye movement latency. 59
Anticipation of age at onset in Panic Disorder. American Journal of Psychiatry,155 (5):590-595, 1998 59
CARDIAC AUTONOMIC FUNCTION DURING SLEEP OF NEVER-DEPRESSED BORDERLINE SUBJECTS - A PILOT-STUDY 59
Fat mass and obesity-associated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with bulimia nervosa and anorexia nervosa 59
EEG power modifications in obsessive-compulsive disorder during olfactory stimulation 58
Further studies on the major histocompatibility complex as a genetic marker for schizophrenia. 58
Psychophysiological patterns of children at risk for panic disorder 58
Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction 58
Decision-making heterogeneity in obsessive-compulsive disorder: Ventromedial prefrontal cortex function predicts different treatment outcomes 57
Complex segregation analysis for obsessive compulsive disorder and related disorders 57
Histocompatibility antigens and effects of neuroactive drugs on phytohaemagglutinin stimulation of lymphocytes in vitro. 57
Schizotypy in Partners of Patients with Schizotypal Personality Disorder 57
Low social interactions in eating disorder patients in childhood and adulthood: a multi-centre European case control study. 57
Functional promoter polymorphism of the human serotonin transporter: Lack of association with panic disorder 57
HYPERSENSITIVITY TO INHALATION OF CARBON-DIOXIDE AND PANIC ATTACKS 56
Personality Features Related to Generalized Anxiety Disorder. 55
Serotonergic modulation of the balance system in panic disorder: An open study 55
First-cycle REM density in never-depressed subjects with Borderline personality disorder. Biological Psychiatry 45: 1056-1058, 1999 55
Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response. 55
Fluvoxamine treatment and D-2 receptors: a pet study on OCD drug-naive patients 54
Common genetic, clinical; demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders 54
Psychoimmunoendocrine aspects of panic disorder. 54
Morbidity risk for obsessive-compulsive spectrum disorders in first-degree relatives of patients with eating disorders 54
Cardiac autonomic function during sleep of never-depressed Borderline subjects: a pilot study. Journal of Psychiatric Research, 29: 397-405, 1995 54
Subclinical Impairment of Lung Airways in Patients with Panic Disorder. 54
Promoter polymorphisms of the 5HT2C receptor gene: Association study with panic disorder in two independent samples. 54
Genetic variants of dopamine receptor D4 and psychopathology 54
Possible linkage between primary affective disorder susceptibility locus and HLA haplotypes. 54
Sensitivity to 35% carbon dioxide in patients with generalized anxiety disorder 54
Proclactin secretion and response to stimuli in male heroin addicts. 53
DSM III-R Personality Disorders in Panic Disorder. 53
Temperament dimensions explain the comorbidity of psychiatric disorders 53
Citalopram and panic disorder. 53
Comorbidity of Panic and Somatization disorder: a genetic epidemiological approach. Comprehensive Psychiatry, 36 (6): 411-420, 1995 53
The unipolar-bipolar dichotomy and the response to sleep deprivation 53
COMORBIDITY OF PANIC AND SOMATIZATION DISORDER - A GENETIC-EPIDEMIOLOGIC APPROACH 52
Further study on N1-methylnicotinamide urinary output in patients with affective disorders. 52
Health-related quality of life in euthymic bipolar disorder patients: Differences between bipolar I and II subtypes 52
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study 51
Anticipation of age at onset in panic disorder 51
The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: An open study 51
Polymorphic MAO-A and 5-HT-transporter genes: analysis of interactions in panic disorder. 51
Family study of schizophrenia: exploratory analysis for relevant factors. 51
Evaluation of mother-child agreement and factorial structures of the SCARED questionnaire in an Italian clinical sample 51
Bulimia nervosa, 5-HTTLPR polymorphism and treatment response to four SSRIs: a single-blind study 51
Growth hormone response to growth hormone-releasing hormone stimulation in obsessive-compulsive disorder 51
Analytic considerations about distribution of age of onset in schizophrenia. 51
The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after week of treatment with citalopram: An open study 51
The structure of DSM-III-R schizotypal personality disorder diagnosed by direct interviews. Schizophrenia Bulletin, 23 (1) 83-92, 1997 50
Tryptophan depletion in obsessive-compulsive patients 50
No association between eating disorders, obsessive-compulsive disorder and 1438G/A 5-HT2A promoter polymorphism in an Italian population. 50
Does the brain noradrenaline network mediate the effects of the CO2 challenge? 49
Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines 49
CO2-induced panic attacks: A twin study 49
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder 49
The calpain-calpastatin system in obsessive-compulsive disorder 49
Totale 6.674
Categoria #
all - tutte 94.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202293 0 0 0 39 9 5 4 6 3 8 2 17
2022/20231.289 528 313 98 8 4 128 79 80 37 3 3 8
2023/2024454 10 8 38 52 30 128 15 35 5 14 15 104
2024/20252.631 379 62 24 62 46 232 278 183 558 436 201 170
2025/20268.452 606 684 777 1.382 460 272 865 614 2.441 351 0 0
Totale 12.944